Delivery Order SPE2DB22D3009-SPE2DB25FAH19

Award Date 10/24/24
Potential Completion Date 10/25/24
Potential Value $4.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $4,329.54, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 100 count bottles of 60 mg extended-release diltiazem hydrochloride capsules, a cardiovascular medication. The award is a delivery order under a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical....
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,937.74, is for the delivery of Diltiazem 12HR ER 60 mg capsules and has a completion date of March 19, 2024. The contract is a firm fixed price agreement and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,565,124,081 units of the drug Diltiazem 12HR ER 60 mg capsules in quantities of 100s. The award is a Firm Fixed Price Delivery Order with a ceiling value of $4,554.30 and an ultimate completion date of July 12, 2024. The contract is not designated as a set-aside. AmerisourceBergen...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,809.05, is for the delivery of Diltiazem 12HR ER 60 MG capsules. The contract is a Firm Fixed Price Delivery Order with a period of performance through January 9, 2024. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award, valued at $1,108.15, is for the delivery of Diltiazem 12HR ER 60 mg capsules in 100 count packages. This is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. The IDC, valued...
This federal contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, valued at $1,492.39, is for the delivery of Diltiazem 12HR ER 60 MG capsules in 100-count packages. This is a firm fixed price delivery order contract with no set-aside designation. Amerisourcebergen Drug Corp also holds an Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,370.87 firm fixed-price delivery order is for the supply of Diltiazem 12HR ER 60 MG capsules, a cardiovascular medication. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive range of...
This federal contract award, valued at $1,813.65, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 90 units of the medication Diltiazem 24H ER (LA) 300 mg. The contract is a firm fixed-price delivery order with an ultimate completion date of April 17, 2025. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $100,440.00, is for the delivery of Diltiazem 60mg tablets in quantities of 100 pills. The contract type is a Delivery Order with a Firm Fixed Price pricing structure, and the ultimate completion date is September 30, 2015. The contract was not set aside for any specific...
This is a federal contract award made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,476.06 firm fixed-price delivery order is for the supply of DILTIAZEM 12HR ER 60 MG CAP 100S, a cardiovascular medication. The award is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
  • SPE2DB22D3009
    Indefinite Delivery Contract
  • SPE2DB22D3009-SPE2DB25FAH19
    Delivery Order

This federal contract award, valued at $4,451.26, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 100 counts of Diltiazem 12HR ER 120 mg capsules, a cardiovascular medication.

The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

In addition to the DLA contract, AmerisourceBergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 1/23/25, 9:27 AM